Kinetic and stoichiometric analysis of the modification process for N-terminal PEGylation of staphylokinase

Analytical Biochemistry

Volumn 412, Issue 1, 2011, Pages 114-116

  Wang, Jun ^a,b   Hu, Tao ^a   Liu, Yongdong ^a   Zhang, Guifeng ^a   Ma, Guanghui ^a   Su, Zhiguo ^a  

^a INSTITUTE OF PROCESS ENGINEERING   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG THERAPY;

ACUTE MYOCARDIAL INFARCTION; AMINO ACID RESIDUES; MODIFICATION PROCESS; N-TERMINALS; PHARMACOLOGICAL PROFILES; THERAPEUTIC PROTEIN; THROMBOLYTIC THERAPIES; TRYPTIC PEPTIDES;

SIZE EXCLUSION CHROMATOGRAPHY;

MACROGOL; STAPHYLOKINASE;

ACUTE HEART INFARCTION; AMINO TERMINAL SEQUENCE; ARTICLE; DRUG INDICATION; ENZYME KINETICS; ENZYME MODIFICATION; FIBRINOLYTIC THERAPY; GEL PERMEATION CHROMATOGRAPHY; PEPTIDE MAPPING; PRIORITY JOURNAL; STOICHIOMETRY;

EID: 79952450902     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2010.12.030     Document Type: Article

References (15)

1. M.I. Bokarewa, T. Jin, and A. Tarkowski Staphylococcus aureus: staphylokinase Int. J. Biochem. Cell Biol. 38 2006 504 509 (Pubitemid 43117575)
2. D. Collen, B. Schlott, Y. Engelborghs, B. Van Hoef, M. Hartmann, H.R. Lijnen, and D. Behnke On the mechanism of the activation of human plasminogen by recombinant staphylokinase J. Biol. Chem. 268 1993 8284 8289 (Pubitemid 23120419)
3. S. Vanwetswinkel, S. Plaisance, Z. Zhi-Yong, I. Vanlinthout, K. Brepoels, I. Lasters, D. Collen, and L. Jespers Pharmacokinetic and thrombolytic properties of cysteine-linked polyethylene glycol derivatives of staphylokinase Blood 95 2000 936 942 (Pubitemid 30062715)
4. D. Collen, P. Sinnaeve, E. Demarsin, H. Moreau, M. DeMaeyer, L. Jespers, and Y. Laroche Polyethylene glycol-derivatized cysteine-substitution variants of recombinant staphylokinase for single-bolus treatment of acute myocardial infarction Circulation 102 2000 1766 1772
5. E.J. Park, and D.H. Na Optimization of octreotide PEGylation by monitoring with fast reversed-phase high-performance liquid chromatography Anal. Biochem. 380 2008 140 142
6. H.F. Gaertner, and R.E. Offord Site-specific attachment of functionalized poly(ethylene glycol) to the amino terminus of proteins Bioconjug. Chem. 7 1996 38 44
7. Y. Nie, X. Zhang, X. Wang, and J. Chen Preparation and stability of N-terminal mono-PEGylated recombinant human endostatin Bioconjug. Chem. 17 2006 995 999 (Pubitemid 44162618)
8. H. Lee, I.H. Jang, S.H. Ryu, and T.G. Park N-terminal site-specific mono-PEGylation of epidermal growth factor Pharm. Res. 20 2003 818 825 (Pubitemid 36515317)
9. O. Kinstler, G. Molineux, M. Treuheit, D. Ladd, and C. Gegg Mono-N-terminal poly(ethylene glycol)-protein conjugates Adv. Drug Deliv. Rev. 54 2002 477 485 (Pubitemid 34615544)
10. J. Lippincott, E. Hess, and I. Apostol Mapping of recombinant hemoglobin using immobilized trypsin cartridges Anal. Biochem. 252 1997 314 325 (Pubitemid 27449715)
11. O. Ohlenschläger, R. Ramachandran, J. Flemming, K-H. Gührs, B. Schlott, and L.R. Brown NMR secondary structure of the plasminogen activator protein staphylokinase J. Biomol. NMR 9 1997 273 286 (Pubitemid 127505388)
12. T. Hu, M. Prabhakaran, S.A. Acharya, and B.N. Manjula Influence of the chemistry of conjugation of poly(ethylene glycol) to Hb on the oxygen-binding and solution properties of the PEG-Hb conjugate Biochem. J. 392 2005 555 564 (Pubitemid 43022735)
13. C.J. Fee, and J.M. Van Alstine PEG-proteins: reaction engineering and separation issues Chem. Eng. Sci. 61 2006 924 939
14. V. Gaberc-Porekar1, I. Zore, B. Podobnik, and V. Menart Obstacles and pitfalls in the PEGylation of therapeutic proteins Curr. Opin. Drug Discov. Dev. 11 2008 242 250 (Pubitemid 351281064)
15. J. Hauptmann, K.H. Guhrs, M. Hartmann, and B. Schlott The fibrinolytic activity of staphylokinase mutants in the fibrin plate assay Haemostasis 25 1995 272 276